📰 Genscript Biotech News
Page 2 - Genscript Biotech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genscript Biotech. Real-time updates on events, politics, business and more.
January 4, 2024
NANJING, China, Jan. 4, 2024 /PRNewswire/ -- On January 10, 2024, the GenScript Biotech Global Forum is set to inaugurate with grandeur during the 42nd J.P. Morgan Healthcare Conference in San...
December 14, 2023
Conference to convene gene- and cell-therapy thought leaders from the research, industry, and capital communities as well as representatives from regulatory bodies PISCATAWAY, N.J., Dec. 14, 2023...
December 7, 2023
NANJING, China, Dec. 7, 2023 /PRNewswire/ -- The rapid advancement of technology has propelled the field of life sciences into unprecedented growth, constantly expanding our understanding and...
December 7, 2023
NANJING, China, Dec. 7, 2023 /PRNewswire/ -- The rapid advancement of technology has propelled the field of life sciences into unprecedented growth, constantly expanding our understanding and imagination. Particularly in the field of cellular gene therapy, a series of recent positive developments have been overwhelming. Recently, the world's first CRISPR/Cas9 gene editing therapy received market approval in the UK....
December 4, 2023
Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report) saw a significant drop in short interest in November. As of November 15th, there was short interest totalling 4,376,100 shares, a drop of 7.4% from the October 31st total of 4,726,000 shares. Based on an average daily volume of 61,000 shares, the days-to-cover ratio is currently 71.7 […]
December 1, 2023
BioSpaces Best Places to Work report celebrates the top 30 small and large biopharma employers across America, and demonstrates a companys desirability in the recruitment marketplace, based on the...
November 18, 2023
Secondary Antibody Market Analysis and Future Prospects for 2030
November 18, 2023
Primary Antibody Market Analysis and Future Prospects for 2030
October 4, 2023
Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report) was the target of a large decline in short interest during the month of September. As of September 15th, there was short interest totalling 4,478,000 shares, a decline of 5.7% from the August 31st total of 4,748,000 shares. Based on an average daily trading volume, of 45,200 […]
September 20, 2023
Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report) saw a large drop in short interest in the month of August. As of August 31st, there was short interest totalling 4,748,000 shares, a drop of 13.9% from the August 15th total of 5,515,500 shares. Based on an average daily trading volume, of 100 shares, the short-interest […]